RELMADA THERAPEUTICS, INC. Accrued Vacation, Current
RELMADA THERAPEUTICS, INC. (RLMD) had Accrued Vacation, Current of $584.80 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Vacation, Current $584.80K.
- 2026-03-31: Accrued Vacation, Current $594.90K.
- 2025-12-31: Accrued Vacation, Current $535.50K.
- 2025-09-30: Accrued Vacation, Current $532.60K.
| Period end | Accrued Vacation, Current |
|---|---|
| 2026-06-30 | $584.80K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $594.90K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $535.50K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $532.60K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $509.80K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $561.90K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $421.70K 10-K · filed 2026-03-19 |
| 2024-09-30 | $395.40K 10-Q · filed 2024-11-07 |
| 2023-12-31 | $372.20K 10-K · filed 2025-03-27 |
| 2023-06-30 | $328.90K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $332.40K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $529.80K 10-K · filed 2024-03-19 |
| 2022-09-30 | $648.30K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $572.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $503.50K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $450.40K 10-K · filed 2023-03-23 |
| 2021-09-30 | $413.50K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $414.40K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $401.20K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $351.20K 10-K · filed 2022-03-25 |
| 2020-09-30 | $312.90K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $232.60K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $204.10K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $124.60K 10-K · filed 2021-03-24 |
| 2019-09-30 | $129.60K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $96.70K 10-K · filed 2021-03-24 |
| 2019-03-31 | $77.80K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $68.30K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $53.70K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $48.00K 10-KT · filed 2020-03-26 |
| 2018-03-31 | $65.30K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $64.90K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $55.80K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $56.90K 10-K · filed 2018-09-28 |
| 2017-03-31 | $68.20K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $65.00K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $75.20K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $66.70K 10-K · filed 2017-09-28 |
| 2016-03-31 | $149.60K 10-Q · filed 2016-05-09 |
| 2015-06-30 | $116.60K 10-K · filed 2016-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |